Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis

• DOI: 10.3350/cmh.2022.0330
• Publication Date: 2023-03-13T00:38:07Z
• Authors: Min Jeong Park; Hayeon Kim; Myeong Gyu Kim; Kyungim Kim
• Keywords: Pioglitazone

Previous studies have revealed that glucagon-like peptide-1 receptor agonist (GLP-1RA) and thiazolidinedione (TZD) can improve nonalcoholic fatty liver disease (NAFLD) or steatohepatitis (NASH). However, comprehensive research comparing the effects of GLP-1RA TZD is limited. Thus, this study aimed to compare on NAFLD NASH through a network meta-analysis.